Search research articles
Contact Us
Filters
Showing results (21-30 of 61) with videos related to
Page
of 7
Sort By:
Molecular and Cellular Biology
|
March 21, 2023
Methyltransferase Inhibition Enables Tgf<b>β</b> Driven Induction of <i>CDKN2A</i> and <i>B</i> in Cancer Cells
Yen-Ting Liu, Celeste Romero, Xue Xiao, et al.
International Journal of Surgery. Oncology
|
March 24, 2022
The addition of autologous stem cell transplantation to neoadjuvant chemotherapy, radiation, and HIPEC for patients with unresectable desmoplastic small round cell tumor: a single center case series
Amir Siddiqui, Navin Pinto, Mark A Applebaum, et al.
Epigenetics
|
August 9, 2022
MYCN and HIF-1 directly regulate <i>TET1</i> expression to control 5-hmC gains and enhance neuroblastoma cell migration in hypoxia
Anastasia E Hains, Sakshi Uppal, John Z Cao, et al.
JCO Clinical Cancer Informatics
|
December 9, 2021
Predicting Response to Chemotherapy in Patients With Newly Diagnosed High-Risk Neuroblastoma: A Report From the International Neuroblastoma Risk Group
Anoop Mayampurath, Siddhi Ramesh, Diana Michael, et al.
Cancer Metastasis Reviews
|
December 15, 2019
Progress toward liquid biopsies in pediatric solid tumors
Daniel A Weiser, Diana C West-Szymanski, Ellen Fraint, et al.
Biorxiv : the Preprint Server for Biology
|
May 10, 2023
5-hydroxymethylcytosine profiling of cell-free DNA identifies bivalent genes that are prognostic of survival in high-risk neuroblastoma
Mohansrinivas Chennakesavalu, Kelley Moore, Gepoliano Chaves, et al.
JCO Precision Oncology
|
January 31, 2024
5-Hydroxymethylcytosine Profiling of Cell-Free DNA Identifies Bivalent Genes That Are Prognostic of Survival in High-Risk Neuroblastoma
Mohansrinivas Chennakesavalu, Kelley Moore, Gepoliano Chaves, et al.
Biorxiv : the Preprint Server for Biology
|
September 11, 2023
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma
Omar R Vayani, Maria E Kaufman, Kelley Moore, et al.
Research Square
|
September 15, 2025
5-hydroxymethylcytosine profiles in circulating cell-free DNA associate with disease status in patients with osteosarcoma
Evan W Neczypor, Hailey Reisert, Kelley Moore, et al.
Pediatric Blood & Cancer
|
October 20, 2023
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma
Omar R Vayani, Maria E Kaufman, Kelley Moore, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 61) with videos related to
Sort By:
Page
of 7
Molecular and Cellular Biology
|
March 21, 2023
Methyltransferase Inhibition Enables Tgf<b>β</b> Driven Induction of <i>CDKN2A</i> and <i>B</i> in Cancer Cells
Yen-Ting Liu, Celeste Romero, Xue Xiao, et al.
International Journal of Surgery. Oncology
|
March 24, 2022
The addition of autologous stem cell transplantation to neoadjuvant chemotherapy, radiation, and HIPEC for patients with unresectable desmoplastic small round cell tumor: a single center case series
Amir Siddiqui, Navin Pinto, Mark A Applebaum, et al.
Epigenetics
|
August 9, 2022
MYCN and HIF-1 directly regulate <i>TET1</i> expression to control 5-hmC gains and enhance neuroblastoma cell migration in hypoxia
Anastasia E Hains, Sakshi Uppal, John Z Cao, et al.
JCO Clinical Cancer Informatics
|
December 9, 2021
Predicting Response to Chemotherapy in Patients With Newly Diagnosed High-Risk Neuroblastoma: A Report From the International Neuroblastoma Risk Group
Anoop Mayampurath, Siddhi Ramesh, Diana Michael, et al.
Cancer Metastasis Reviews
|
December 15, 2019
Progress toward liquid biopsies in pediatric solid tumors
Daniel A Weiser, Diana C West-Szymanski, Ellen Fraint, et al.
Biorxiv : the Preprint Server for Biology
|
May 10, 2023
5-hydroxymethylcytosine profiling of cell-free DNA identifies bivalent genes that are prognostic of survival in high-risk neuroblastoma
Mohansrinivas Chennakesavalu, Kelley Moore, Gepoliano Chaves, et al.
JCO Precision Oncology
|
January 31, 2024
5-Hydroxymethylcytosine Profiling of Cell-Free DNA Identifies Bivalent Genes That Are Prognostic of Survival in High-Risk Neuroblastoma
Mohansrinivas Chennakesavalu, Kelley Moore, Gepoliano Chaves, et al.
Biorxiv : the Preprint Server for Biology
|
September 11, 2023
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma
Omar R Vayani, Maria E Kaufman, Kelley Moore, et al.
Research Square
|
September 15, 2025
5-hydroxymethylcytosine profiles in circulating cell-free DNA associate with disease status in patients with osteosarcoma
Evan W Neczypor, Hailey Reisert, Kelley Moore, et al.
Pediatric Blood & Cancer
|
October 20, 2023
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma
Omar R Vayani, Maria E Kaufman, Kelley Moore, et al.
Page
of 7